27159395 |
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Ganesan, S,
Lane, K,
Sokol, L,
Panda, A,
Damare, S,
Pavlick, DC,
Hirshfield, K,
Zhong, H,
Lovell, A,
Ross, JS,
White, EP,
Bhanot, G,
Kaufman, HL,
DiPaola, RS,
Rodriguez-Rodriquez, L,
Cheng, J,
Mehnert, JM,
Stein, MN,
Ali, S
|
J. Clin. Invest. |
2016 |